Dr. Kory on How Ivermectin Defeats the Variants + The Positive Data in Andrew Hill’s Meta-Analysis of RCTs on Ivermectin in Treating Covid-19.

Authors: Cadegiani FA, Goren A, Wambier CG, McCoy J PMID: 34249367 PMCID: PMC8262389 DOI: 10.1016/j.nmni.2021.100915 Abstract In a prospective observational study (pre-AndroCoV Trial), the use of nitazoxanide, ivermectin and hydroxychloroquine demonstrated unexpected improvements in COVID-19 outcomes when compared to untreated patients. The apparent yet likely positive results raised ethical concerns on the employment of further [...]

Authors: Hill A, Garratt A, Levi J, Falconer J, Ellis L, McCann K et al. PMID: 34796244 PMCID: PMC8420640 DOI: 10.1093/ofid/ofab358 Abstract Ivermectin is an antiparasitic drug being investigated for repurposing against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Ivermectin showed in vitro activity against SARS-COV-2, but only at high concentrations. This meta-analysis investigated ivermectin [...]

Matt Taibbi's substack examines the war on repurposed drugs and asks why has Ivermectin become a dirty word?

Sowetan Live reports that Zimbabwe approved ivermectin to treat COVID-19.

Transcript of Dr. Kory's video message on the U.S. Deal to Give $1.2 Billion Taxpayer Dollars to Merck Instead of distributing safe, effective, inexpensive ivermectin

After COVID-19 emerged on U.S shores, providers began reviewing the emerging basic science, translational, and clinical data to identify potentially effective treatment options. In addition, a multitude of both novel and repurposed therapeutic agents were used empirically and studied within clinical trials.

To evaluate different doses of ivermectin in adult patients with mild COVID-19 and to evaluate the effect of ivermectin on mortality and clinical consequences.

The study, published in the American Journal of Therapeutics, used the highest scientific standards to evaluate the efficacy of ivermectin and found that “large reductions in COVID-19 deaths are possible with the use of ivermectin.”

ivermectin is being investigated in the UK as part of the Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE), the world’s largest clinical trial of possible COVID-19 treatments for recovery at home and in other non-hospital settings.